Volume 4, Issue 2 (April 2025)
Health Science Monitor 2025, 4(2): 150-156 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kazempour Dizaji M, Varahram M, Roozbahani R, Abedini A, Zare A, Nadji S A, et al . Study of hospitalization status of patients with COVID-19 in Dr. Masih Daneshvari Hospital in Tehran. Health Science Monitor 2025; 4 (2) :150-156
URL: http://hsm.umsu.ac.ir/article-1-192-en.html
URL: http://hsm.umsu.ac.ir/article-1-192-en.html
Study of hospitalization status of patients with COVID-19 in Dr. Masih Daneshvari Hospital in Tehran
Mehdi Kazempour Dizaji 
, Mohammad Varahram * , Rahim Roozbahani , Atefe Abedini , Ali Zare , Syeyd Alireza Nadji , Arda Kiani , Niloufar Alizedeh Kolahdozi , Mohammad Ali Emamhadi , Majid Marjani
, Mohammad Varahram * , Rahim Roozbahani , Atefe Abedini , Ali Zare , Syeyd Alireza Nadji , Arda Kiani , Niloufar Alizedeh Kolahdozi , Mohammad Ali Emamhadi , Majid Marjani
Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract: (180 Views)
Background & Aims: The COVID-19 pandemic, caused by a novel coronavirus, has infected over 91 million people globally, with Iran being severely impacted, reporting 7.6 million cases and nearly 946,837 deaths. This study examines hospitalization trends among COVID-19 patients in Iran to improve resource allocation and patient care.
Materials & Methods: A cross-sectional analysis was conducted using data from 4,372 confirmed COVID-19 patients admitted to Dr. Masih Daneshvari Hospital in Tehran during the first 50 days of the outbreak. The study evaluated admissions to general wards and intensive care units (ICUs).
Results: Findings revealed an average daily hospitalization rate of 193.86 patients, with 149.42 (76.94%) admitted to general wards and 44.44 (23.06%) to ICUs. Over time, general ward admissions showed a declining trend, while ICU admissions increased, indicating a potential rise in severe cases.
Conclusion: The study underscores the importance of monitoring hospitalization patterns to optimize medical resources, including equipment, medications, and staffing. By understanding these trends, healthcare systems can enhance hospital efficiency and improve patient care during future outbreaks.
Materials & Methods: A cross-sectional analysis was conducted using data from 4,372 confirmed COVID-19 patients admitted to Dr. Masih Daneshvari Hospital in Tehran during the first 50 days of the outbreak. The study evaluated admissions to general wards and intensive care units (ICUs).
Results: Findings revealed an average daily hospitalization rate of 193.86 patients, with 149.42 (76.94%) admitted to general wards and 44.44 (23.06%) to ICUs. Over time, general ward admissions showed a declining trend, while ICU admissions increased, indicating a potential rise in severe cases.
Conclusion: The study underscores the importance of monitoring hospitalization patterns to optimize medical resources, including equipment, medications, and staffing. By understanding these trends, healthcare systems can enhance hospital efficiency and improve patient care during future outbreaks.
Keywords: COVID-19, Disease severity, Epidemic, General ward, Hospitalization status, Intensive care unit
Type of Study: Research |
Subject:
Applied Biostatistics and Epidemiology
Received: 2024/08/27 | Accepted: 2025/04/23 | Published: 2025/04/30
Received: 2024/08/27 | Accepted: 2025/04/23 | Published: 2025/04/30
References
1. Gouya M, Hemmati P. An overview of Iran's actions in response to the COVID-19 pandemic and in building health system resilience. Frontiers in Public Health. 2023;11:1073259.
https://doi.org/10.3389/fpubh.2023.1073259 [DOI] [PMID] [PMCID]
2. Rezaei S, Mohammadnezhad M. A tale of two times: an exploration of healthcare utilization patterns before and during COVID-19 in Iran. BMC Public Health. 2024;24:2961.
https://doi.org/10.1186/s12889-024-20452-6 [DOI] [PMID] [PMCID]
3. Chowdhury S. Comparative profile of the human coronaviruses. South Asian Journal of Experimental Biology. 2024;14(2):52-60.
https://doi.org/10.38150/sajeb.14(2).p52-60 [DOI]
4. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends. 2020;14(1):69-71.
https://doi.org/10.5582/bst.2020.01047 [DOI] [PMID]
5. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020;91:264-6.
https://doi.org/10.1016/j.ijid.2020.01.009 [DOI] [PMID] [PMCID]
6. World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Geneva: WHO; 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. [URL]
7. Maitra S, Biswas M, Bhattacharjee S. Case-fatality rate in COVID-19 patients: A meta-analysis of publicly accessible database. medRxiv. 2020.
https://doi.org/10.1101/2020.04.09.20059683 [DOI]
8. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. Journal of the American Medical Association. 2020;323(13):1239-42.
https://doi.org/10.1001/jama.2020.2648 [DOI] [PMID]
9. Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. British Medical Journal. 2020;368:m641.
https://doi.org/10.1136/bmj.m641 [DOI] [PMID]
10. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-20.
https://doi.org/10.1056/NEJMoa2002032 [DOI] [PMID] [PMCID]
11. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine. 2020;382(13):1199-207.
https://doi.org/10.1056/NEJMoa2001316 [DOI] [PMID] [PMCID]
12. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514-23.
https://doi.org/10.1016/S0140-6736(20)30154-9 [DOI] [PMID]
13. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews Drug Discovery. 2020;19(3):149-50.
https://doi.org/10.1038/d41573-020-00016-0 [DOI] [PMID]
14. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Bioscience Trends. 2020;14(1):69-71.
https://doi.org/10.5582/bst.2020.01020 [DOI] [PMID]
15. Ezzati F, Mosadeghrad AM, Jaafaripooyan E. Resiliency of the Iranian healthcare facilities against the Covid-19 pandemic: challenges and solutions. BMC Health Services Research. 2023;23:207.
https://doi.org/10.1186/s12913-023-09180-6 [DOI] [PMID] [PMCID]
16. Jabbari A, Salahi S, Hadian M, et al. Exploring the challenges of Iranian government hospitals related to Covid-19 pandemic management: a qualitative content analysis research from the nurses perspective. BMC Nursing. 2022;21:226.
https://doi.org/10.1186/s12912-022-01008-8 [DOI] [PMID] [PMCID]
17. Mehrizi R, Golestani A, Malekpour MR, Karami H, Nasehi MM, Effatpanah M, et al. Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors. PLoS ONE. 2024;19(2):e0298604.
https://doi.org/10.1371/journal.pone.0298604 [DOI] [PMID] [PMCID]
18. Roback JD, Guarner J. Convalescent plasma to treat COVID-19: possibilities and challenges. Journal of the American Medical Association. 2020;323(16):1561-2.
https://doi.org/10.1001/jama.2020.4940 [DOI] [PMID]
19. Peng L, Yang W, Zhang D, Zhuge C, Hong L. Epidemic analysis of COVID-19 in China by dynamical modeling. arXiv preprint arXiv:2002.06563. 2020. https://arxiv.org/abs/2002.06563. [DOI]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
